Yarbrough Capital’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,705
Closed -$602K 185
2025
Q1
$602K Hold
4,705
0.03% 123
2024
Q4
$719K Hold
4,705
0.03% 114
2024
Q3
$842K Sell
4,705
-3,030
-39% -$527K 0.03% 98
2024
Q2
$1.26M Buy
7,735
+2,130
+38% +$346K 0.05% 80
2024
Q1
$980K Hold
5,605
0.04% 95
2023
Q4
$944K Buy
5,605
+2,575
+85% +$375K 0.05% 94
2023
Q3
$435K Hold
3,030
0.03% 134
2023
Q2
$558K Hold
3,030
0.03% 126
2023
Q1
$482K Hold
3,030
0.04% 131
2022
Q4
$412K Hold
3,030
0.03% 114
2022
Q3
$350K Buy
+3,030
New +$413K 0.03% 139

Other funds holding NOVT

Yarbrough Capital's NOVT Position: Q2 2025 in Review

Yarbrough Capital sold out of Novanta (NOVT) in Q2 2025, closing a stake of 4,705 shares — an estimated $602K sold.

Yarbrough Capital first reported a position in NOVT in Q3 2022 and held it in 11 quarters. The position peaked at $1.26M in Q2 2024. 326 funds tracked by Wall St. Rank hold NOVT as of Q2 2025.

  • Yarbrough Capital reported no remaining Novanta position as of Q2 2025 after selling out during the quarter.
  • Yarbrough Capital sold 4,705 Novanta shares in Q2 2025, an estimated $602K.
  • Yarbrough Capital first reported a position in Novanta in Q3 2022 and held it in 11 quarters.
  • Yarbrough Capital's Novanta position peaked at $1.26M in Q2 2024.
  • 326 funds tracked by Wall St. Rank held Novanta as of Q2 2025.

Based on Yarbrough Capital's 13F filing for Q2 2025, filed 15 Jul 2025.